A group of US Senators is calling on the federal government to loosen the red tape that’s put a chokehold on cannabis research.
In a recent report attached to the Departments of Labor and Health and Human Services for Fiscal Year 2019, the Senate Appropriations Committee used strong language to push for cannabis reform.
More specifically, the Committee wants to enable researchers to properly research cannabis. The classification of cannabis as a Schedule I drug in the Controlled Substances Act makes it extremely difficult to study given the hoops that researchers must jump through to get access to the highly restricted substance. This means the effects and applications of cannabis are vastly under-studied, and cannot be truly understood until more research is done.
“The Committee is concerned that restrictions associated with Schedule 1 of the Controlled Substance Act effectively limit the amount and type of research that can be conducted on certain Schedule